41270-66-0: Selexipag In-house Impurity C
It is act as agonists of the prostacyclin receptor to increase vasodilation and its active metabolite are highly protein bound.
Additional information on CAS 41270-66-0
Coghlan, J. Gerry, et al. “Selexipag in the Management of Pulmonary Arterial Hypertension: An Update.” Drug, Healthcare and Patient Safety, vol. Volume 11, Aug. 2019, pp. 55–64, https://doi.org/10.2147/dhps.s181313.
Other products related to selexipag
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|